Voloridge Investment Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
Voloridge Investment Management's HAE Position: Q3 2022 in Review
Voloridge Investment Management sold out of Haemonetics (HAE) in Q3 2022, closing a stake of 100,315 shares — an estimated $6.54M sold.
Voloridge Investment Management first reported a position in HAE in Q4 2017 and held it in 13 quarters. The position peaked at $13.8M in Q2 2021. 270 funds tracked by Wall St. Rank hold HAE as of Q3 2022.
- Voloridge Investment Management reported no remaining Haemonetics position as of Q3 2022 after selling out during the quarter.
- Voloridge Investment Management sold 100,315 Haemonetics shares in Q3 2022, an estimated $6.54M.
- Voloridge Investment Management first reported a position in Haemonetics in Q4 2017 and held it in 13 quarters.
- Voloridge Investment Management's Haemonetics position peaked at $13.8M in Q2 2021.
- 270 funds tracked by Wall St. Rank held Haemonetics as of Q3 2022.
Based on Voloridge Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.